rs12615435
From SNPedia
Orientation | plus |
Stabilized | plus |
Make rs12615435(G;G) |
Make rs12615435(G;T) |
Make rs12615435(T;T) |
Reference | GRCh38 38.1/141 |
Chromosome | 2 |
Position | 199773786 |
Gene | FTCDNL1, LOC107985974 |
is a | snp |
is | mentioned by |
dbSNP | rs12615435 |
dbSNP (classic) | rs12615435 |
ClinGen | rs12615435 |
ebi | rs12615435 |
HLI | rs12615435 |
Exac | rs12615435 |
Gnomad | rs12615435 |
Varsome | rs12615435 |
LitVar | rs12615435 |
Map | rs12615435 |
PheGenI | rs12615435 |
Biobank | rs12615435 |
1000 genomes | rs12615435 |
hgdp | rs12615435 |
ensembl | rs12615435 |
geneview | rs12615435 |
scholar | rs12615435 |
rs12615435 | |
pharmgkb | rs12615435 |
gwascentral | rs12615435 |
openSNP | rs12615435 |
23andMe | rs12615435 |
SNPshot | rs12615435 |
SNPdbe | rs12615435 |
MSV3d | rs12615435 |
GWAS Ctlg | rs12615435 |
GMAF | 0.09917 |
Max Magnitude | 0 |
? | (G;G) (G;T) (T;T) | 28 |
---|---|---|
|
GWAS snp | |
---|---|
PMID | [PMID 23648065![]() |
Trait | Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs) |
Title | Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan. |
Risk Allele | T |
P-val | 4E-6 |
Odds Ratio | 2.21 [1.555-3.154] |